Police & Firemen's Retirement System of New Jersey’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$770K Buy
16,565
+1,511
+10% +$72.6K 0.01% 1571
2026
Q1
$778K Buy
15,054
+756
+5% +$38.5K 0.01% 1406
2025
Q4
$711K Sell
14,298
-1,032
-7% -$50.2K 0.01% 1450
2025
Q3
$733K Buy
15,330
+3,612
+31% +$145K 0.01% 1446
2025
Q2
$369K Buy
11,718
+788
+7% +$25.3K ﹤0.01% 1664
2025
Q1
$358K Hold
10,930
﹤0.01% 1621
2024
Q4
$395K Buy
+10,930
New +$385K ﹤0.01% 1608

Other funds holding SUPN

Police & Firemen's Retirement System of New Jersey's SUPN Position: Q2 2026 in Review

Police & Firemen's Retirement System of New Jersey increased its Supernus Pharmaceuticals (SUPN) stake by 10% in Q2 2026, buying an estimated $72.6K and bringing the position to 16,565 shares worth $770K. The position accounts for 0.01% of the portfolio, ranked #1571.

Police & Firemen's Retirement System of New Jersey first reported a position in SUPN in Q4 2024 and has held it in 7 quarters since. The position peaked at $778K in Q1 2026. 143 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Police & Firemen's Retirement System of New Jersey held 16,565 shares of Supernus Pharmaceuticals worth $770K as of Q2 2026.
  • Police & Firemen's Retirement System of New Jersey bought 1,511 Supernus Pharmaceuticals shares in Q2 2026, an estimated $72.6K.
  • Supernus Pharmaceuticals made up 0.01% of Police & Firemen's Retirement System of New Jersey's portfolio in Q2 2026, its #1571 holding.
  • Police & Firemen's Retirement System of New Jersey first reported a position in Supernus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Police & Firemen's Retirement System of New Jersey's Supernus Pharmaceuticals position peaked at $778K in Q1 2026.
  • 143 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Police & Firemen's Retirement System of New Jersey's 13F filing for Q2 2026, filed 23 Jul 2026.